Access for All

Access for All is a project of @hopemattersmost.

[Access for All @A4AllProject]

As more and more insurers drop prior auth requirements, AFA urges other coverage providers to do away with the policy.

Red tape shouldn’t stand between patients and a treatment their doctor prescribes. https://t.co/zlep4KhaSo

[Access for All @A4AllProject]

Voluntary prior auth cuts make good headlines, but they fail to deliver if patients in need don’t reap the benefits.

Patients need clear standards, not insurers picking which barriers to drop. https://t.co/o3UCKS1tJC

[Access for All @A4AllProject]

Diagnostic tools are advancing rapidly, but outdated coverage rules fail to keep up. It’s time to modernize Medicare and expand early screening access for Alzheimer's by supporting the ASAP Act. More in @thehill: https://t.co/ZBxMZDSwSy

[Access for All @A4AllProject]

Outdated Medicare rules block access to blood tests that may detect Alzheimer's early.

Read a new op-ed in @thehill on why the bipartisan ASAP Act will help ensure coverage keeps pace with science.
https://t.co/ZBxMZDSwSy

[Access for All @A4AllProject]

With over 6.7 million Americans facing Alzheimer’s, outdated Medicare rules shouldn't delay access to innovative diagnostic tools.

As screening technology advances, federal policy needs to keep pace. Check out @CZ's new piece in @POLITICO: https://t.co/gYclY1Y1a9

[Access for All @A4AllProject]

Science is delivering earlier Alzheimer's diagnostic tools, but Medicare policy is lagging behind.

The bipartisan ASAP Act helps close that gap for patients. Read @CZ's new piece in @POLITICO on expanding access to early detection: https://t.co/gYclY1Y1a9

[Access for All @A4AllProject]

A breakthrough in early detection for Alzheimer’s only matters if patients can access it.

The bipartisan ASAP Act can help Medicare keep pace with the science. We teamed up with @PoliticoFocus to explain: https://t.co/gYclY1Y1a9

[Access for All @A4AllProject]

The Alzheimer's drug pipeline is producing real results, but policies may be limiting who can benefit.

Patients who can't get coverage for screening tests may miss the intervention window. Coverage for early detection should keep up with the science. https://t.co/4EKooqt0RL

[Access for All @A4AllProject]

New Alzheimer's treatments could be a beacon of hope for patients and their families. However, therapies designed for early-stage disease work best if the disease is caught early, which requires patient access to screening. Read more:

https://t.co/4EKooqt0RL

[Access for All @A4AllProject]

Momentum is building for earlier Alzheimer’s detection.

As we recognize World Alzheimer’s Month, the ASAP Act has advanced out of @WaysandMeansGOP, bringing Medicare coverage of FDA-approved blood tests one step closer.  We need to pass the ASAP Act!

https://t.co/kpuVXBQ24F

[Access for All @A4AllProject]

This World Alzheimer's Month, let's expand access to early detection. FDA-approved blood tests may help detect Alzheimer's early, yet Medicare doesn't cover them. The ASAP Act would change that, opening the door for earlier detection and improved outcomes.
https://t.co/kpuVXBQ24F

[Access for All @A4AllProject]

AFA recently submitted a comment to @CMSGov urging the agency to prioritize access to diagnostic tools and preventive care. Read more here: https://t.co/inNYxpY53w

[Access for All @A4AllProject]

Read AFA’s new comment to @CMSGov highlighting the importance of access to screening tests & preventive care:

https://t.co/inNYxpY53w

[Access for All @A4AllProject]

Catching conditions like Alzheimer’s early through blood-based biomarker screenings gives patients answers sooner and precious time to plan ahead.

https://t.co/5KWC24RwpW

[Access for All @A4AllProject]

Big step forward! Thank you to the @WaysandMeansGOP and @WaysMeansCmte for unanimously advancing the ASAP Act.

Expanding access to blood-based biomarker tests helps end long diagnostic delays to get patients the care they need when time matters most.
https://t.co/kpuVXBPuf7

[Access for All @A4AllProject]

Thank you to the @HouseCommerce Committee for highlighting the ASAP Act in Tuesday's hearing.

Catching Alzheimer's early through blood tests gives patients and their families precious time to plan, access treatment, and prepare when it matters most.

https://t.co/FA580yWgrf

[Access for All @A4AllProject]

Modern diagnostic tools are advancing rapidly, but outdated Medicare rules continue to delay patient access.

Check out a new podcast from @newtgingrich on why the ASAP Act is essential to ensure seniors can access early Alzheimer's screening and diagnoses.

[Newt Gingrich @newtgingrich]

Dr. Brent Beasley spent his career treating patients. Then, at 57, he was diagnosed with Alzheimer’s himself.

After receiving treatment, he walked out of church one day, turned to his wife and said, “I’m back.”

His remarkable story gives us reason for hope. https://t.co/S4ZkCHPJLS

[Access for All @A4AllProject]

Early detection gives patients the gift of time. The ASAP Act makes that possible.

AFA applauds @HouseCommerce Committee for including the ASAP Act, which will expand access to Alzheimer’s blood tests, in yesterday’s hearing.
https://t.co/EIJ9Nuw25v

[Access for All @A4AllProject]

On a new episode of Newt’s World, @newtgingrich talks to @DrBobRedfield51 and Dr. Brent Beasley about why early Alzheimer's detection is critical. Learn why passing the ASAP Act, which updates Medicare rules to cover diagnostic tools, is so important: https://t.co/Ir1yrMyphe

[Access for All @A4AllProject]

We applaud @HouseCommerce for highlighting needed Medicare policy updates to keep pace with science.

AFA urges lawmakers to back the ASAP Act and ensure Medicare rules don't delay diagnostic tools. It's time to put patients first.

https://t.co/R7xQ1rGE2d